zileuton has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W; Hu, Y; Tang, D | 1 |
| Cuperlovic-Culf, M; Ferguson, D; Hébert, MJ; Jean-François, J; LeBlanc, LM; Morin, P; Paré, AF; Surette, ME; Touaibia, M | 1 |
2 other study(ies) available for zileuton and Astrocytoma, Grade IV
| Article | Year |
|---|---|
5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via β-catenin-dependent pathway.
Topics: Animals; Arachidonate 5-Lipoxygenase; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Mice; Temozolomide | 2023 |
NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.
Topics: Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Caffeic Acids; Cell Line, Tumor; Drug Screening Assays, Antitumor; Free Radical Scavengers; Glioblastoma; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxyurea; Leukotrienes; Lipid Metabolism; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Phenylethyl Alcohol; Principal Component Analysis | 2013 |